Peking University Third Hospital: Amyotrophic Lateral Sclerosis trials

The registry lists 21 Amyotrophic Lateral Sclerosis studies with Peking University Third Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Early Phase 1 3Phase 2 4Phase 3 1Phase 4 1No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in Patients with Amyotrophic Lateral Sclerosis (ALS): a Randomized, Crossover, Controlled, Double-Blind Clinical StudyNot yet recruitingNCT06819358Early Phase 1
• An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral SclerosisNot yet recruitingNCT06645197Early Phase 1
• Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS PatientsRecruitingNCT05923905Phase 4
• Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in ChinaEnrolling by invitationNCT04961450
• Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)RecruitingNCT04454892
• Multimodal Brain Imaging StudyStatus unknownNCT04960540
• Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related DiseasesStatus unknownNCT04956822
• Appetite and Related Factors in Patients With ALSStatus unknownNCT04953624
• Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral SclerosisStatus unknownNCT04953494
• Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral SclerosisStatus unknownNCT04953481
• Low Dose IL-2 in the Treatment of Immune-associated ALS SyndromeStatus unknownNCT04952155Phase 2
• Sleep Disorders and the Onset and Progression of ALSStatus unknownNCT04952038
• Quantitative Analysis of Precise Brain Volume in Amyotrophic Lateral SclerosisCompletedNCT04952025
• The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji GranulesStatus unknownNCT04950933Phase 2/3
• Efficacy and Safety of Nitrazine in the Treatment of ALSStatus unknownNCT04950647Phase 2
• Investigation on Home Care Needs of ALS Patients and Their CaregiversCompletedNCT04950231
• Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral SclerosisCompletedNCT04948346
• Peripheral Neurofilament Levels and Amyotrophic Lateral SclerosisCompletedNCT04455542
• Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral SclerosisCompletedNCT04454840Early Phase 1
• Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland ChinaStatus unknownNCT04328675
• A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT01935518Phase 2